Certis Oncology enables individual cancer patients to cryo-preserve or “bank” their tumors for future research.
Once a patient’s Orthotopic PDX tumor is growing in mice, it can be transplanted from mouse to mouse, effectively making it immortal.
Cryopreserving these tumors helps patients benefit from drug treatments and from gene sequencing technologies that will be developed in the future.
With Certis Oncology tumor banking, chemo-targeted therapies and anti-body based therapies can be administered according to a clinical protocol.
That means that Certis Oncology patients can take advantage of the rapid rate at which cancer research is advancing.
To learn more about Certis Oncology Tumor Banking opportunities, reach out to us at email@example.com.